These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Moxalactam therapy for bacterial infections. Winston DJ; Busuttil RW; Kurtz TO; Young LS Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253 [TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy. Fitzpatrick BJ; Standiford HC Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237 [TBL] [Abstract][Full Text] [Related]
7. Therapy of lower respiratory tract infections with moxalactam. Lentino JR; Rytel MW; Moore E Antimicrob Agents Chemother; 1981 May; 19(5):801-6. PubMed ID: 6457557 [TBL] [Abstract][Full Text] [Related]
8. New drug evaluations: moxalactam (Moxam, Eli Lilly). Polk RE Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections. Murphy TF; Barza M Antimicrob Agents Chemother; 1982 Apr; 21(4):568-74. PubMed ID: 6211137 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia. Saito A Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575 [TBL] [Abstract][Full Text] [Related]
11. Moxalactam therapy of bacterial meningitis in adults. Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673 [TBL] [Abstract][Full Text] [Related]
16. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases]. Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789 [No Abstract] [Full Text] [Related]
17. Moxalactam therapy for a wide spectrum of bacterial infections in adults. Tofte RW; Rotschafer J; Solliday J; Crossley KB Antimicrob Agents Chemother; 1981 May; 19(5):740-4. PubMed ID: 6457555 [TBL] [Abstract][Full Text] [Related]
18. A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli. DeMaria A; McCabe WR Scand J Infect Dis; 1984; 16(1):83-97. PubMed ID: 6695159 [TBL] [Abstract][Full Text] [Related]
19. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli. Fisher JF; Carter MJ; Parsons J; Rissing JP Antimicrob Agents Chemother; 1981 Feb; 19(2):218-21. PubMed ID: 6214985 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency. Trager GM; Panwalker AP; Malow JB; Porembski PE; Ramirez CA; Zar FA Chemotherapy; 1981; 27(4):287-95. PubMed ID: 6454542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]